Nano-bio interactions: a neutrophil-centric view.


Journal

Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092

Informations de publication

Date de publication:
29 07 2019
Historique:
received: 07 06 2019
accepted: 09 07 2019
revised: 04 07 2019
entrez: 31 7 2019
pubmed: 31 7 2019
medline: 4 8 2020
Statut: epublish

Résumé

Neutrophils are key components of the innate arm of the immune system and represent the frontline of host defense against intruding pathogens. However, neutrophils can also cause damage to the host. Nanomaterials are being developed for a multitude of different purposes and these minute materials may find their way into the body through deliberate or inadvertent exposure; understanding nanomaterial interactions with the immune system is therefore of critical importance. However, whereas numerous studies have focused on macrophages, less attention is devoted to nanomaterial interactions with neutrophils, the most abundant leukocytes in the blood. We discuss the impact of engineered nanomaterials on neutrophils and how neutrophils, in turn, may digest certain carbon-based materials such as carbon nanotubes and graphene oxide. We also discuss the role of the corona of proteins adsorbed onto the surface of nanomaterials and whether nanomaterials are sensed as pathogens by cells of the immune system.

Identifiants

pubmed: 31358731
doi: 10.1038/s41419-019-1806-8
pii: 10.1038/s41419-019-1806-8
pmc: PMC6662811
doi:

Substances chimiques

Inflammasomes 0
Nanotubes, Carbon 0
Protein Corona 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

569

Références

ACS Nano. 2016 Aug 23;10(8):7385-400
pubmed: 27439019
J Cell Biol. 2007 Jan 15;176(2):231-41
pubmed: 17210947
Eur J Cell Biol. 2014 Aug-Sep;93(8-9):347-54
pubmed: 25172775
Nat Rev Immunol. 2006 Mar;6(3):173-82
pubmed: 16498448
ACS Nano. 2018 Nov 27;12(11):10582-10620
pubmed: 30387986
J Immunol. 2012 Apr 1;188(7):3150-9
pubmed: 22351936
Sci Rep. 2018 May 14;8(1):7506
pubmed: 29760395
Nanoscale. 2014 Jun 21;6(12):6974-83
pubmed: 24835568
Semin Immunol. 2017 Dec;34:52-60
pubmed: 29066063
Semin Immunol. 2007 Feb;19(1):3-10
pubmed: 17275324
NPJ Vaccines. 2017 Jan 23;2:1
pubmed: 29263862
Nat Nanotechnol. 2013 Feb;8(2):137-43
pubmed: 23334168
Nat Immunol. 2008 Aug;9(8):847-56
pubmed: 18604214
Angew Chem Int Ed Engl. 2018 Sep 3;57(36):11722-11727
pubmed: 30006967
Nat Nanotechnol. 2013 Oct;8(10):772-81
pubmed: 24056901
Chem Biol Interact. 2015 Jun 25;235:106-14
pubmed: 25920576
Front Immunol. 2017 Jun 13;8:673
pubmed: 28659915
ACS Nano. 2015;9(4):3866-74
pubmed: 25849074
Proc Natl Acad Sci U S A. 2010 May 25;107(21):9813-8
pubmed: 20439745
Toxicol Appl Pharmacol. 2016 May 15;299:58-69
pubmed: 26768553
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9035-40
pubmed: 18577586
Nature. 2006 Mar 9;440(7081):237-41
pubmed: 16407889
Sci Immunol. 2018 Aug 24;3(26):
pubmed: 30143555
Front Immunol. 2018 Oct 02;9:2266
pubmed: 30333831
ACS Nano. 2017 Nov 28;11(11):10797-10807
pubmed: 29028303
Cell Microbiol. 2006 Apr;8(4):668-76
pubmed: 16548892
Front Immunol. 2013 Jun 10;4:138
pubmed: 23772226
Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2817-22
pubmed: 25730848
Cell Rep. 2014 Jul 24;8(2):570-82
pubmed: 25043180
Elife. 2017 Jun 02;6:
pubmed: 28574339
ACS Nano. 2018 Apr 24;12(4):3836-3852
pubmed: 29543433
Science. 2017 Dec 1;358(6367):1202-1206
pubmed: 29191910
Trends Immunol. 2015 Jul;36(7):419-27
pubmed: 26088391
Nat Nanotechnol. 2018 Sep;13(9):862-869
pubmed: 29915272
Cell Death Dis. 2018 Jan 25;9(2):111
pubmed: 29371616
J Am Chem Soc. 2012 Mar 7;134(9):4100-3
pubmed: 22339401
Nat Med. 2016 Feb;22(2):146-53
pubmed: 26779811
Nature. 2002 Dec 19-26;420(6917):846-52
pubmed: 12490957
Nanomedicine. 2016 Aug;12(6):1615-25
pubmed: 27015767
Front Physiol. 2018 Mar 13;9:217
pubmed: 29593572
Toxicol In Vitro. 2010 Apr;24(3):1002-8
pubmed: 20005940
ACS Biomater Sci Eng. 2018 Dec 10;4(12):4255-4265
pubmed: 31497639
Environ Health Perspect. 2010 Dec;118(12):1699-706
pubmed: 20729176
Nat Commun. 2019 May 27;10(1):2331
pubmed: 31133680
Cell. 2019 Jan 10;176(1-2):113-126.e15
pubmed: 30633902
Toxicol Appl Pharmacol. 2012 Jun 1;261(2):121-33
pubmed: 22513272
Small. 2013 May 27;9(9-10):1595-607
pubmed: 23180683
PLoS One. 2012;7(3):e30923
pubmed: 22479306
Nature. 2008 Jul 24;454(7203):428-35
pubmed: 18650913
J Clin Invest. 2013 Jul;123(7):3061-73
pubmed: 23778144
Small. 2013 May 27;9(9-10):1546-56
pubmed: 23038664
Nat Commun. 2018 Oct 16;9(1):4291
pubmed: 30327464
Part Fibre Toxicol. 2010 Apr 16;7:10
pubmed: 20398356
Nanomedicine. 2016 Feb;12(2):333-51
pubmed: 26707820
J Cell Physiol. 2019 May;234(5):5436-5450
pubmed: 30370619
Nat Commun. 2018 Oct 31;9(1):4548
pubmed: 30382085
Cell Death Differ. 2009 Nov;16(11):1438-44
pubmed: 19609275
Trends Immunol. 2013 Jul;34(7):317-28
pubmed: 23540649
Innate Immun. 2010 Jun;16(3):191-200
pubmed: 20529971
Nat Nanotechnol. 2010 May;5(5):354-9
pubmed: 20364135
Exp Oncol. 2012 Oct;34(3):139-45
pubmed: 23069997
Nat Nanotechnol. 2011 Jan;6(1):39-44
pubmed: 21170037
Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):E9618-E9625
pubmed: 29078325
Small. 2013 Aug 26;9(16):2721-9, 2720
pubmed: 23447468
Chem Res Toxicol. 2018 Oct 15;31(10):1061-1068
pubmed: 30207453
ACS Nano. 2017 Feb 28;11(2):1884-1893
pubmed: 28112950
Nanotoxicology. 2019 Aug;13(6):761-782
pubmed: 30760074
Adv Drug Deliv Rev. 2013 Dec;65(15):2070-7
pubmed: 23726945
Acta Biomater. 2018 Oct 1;79:283-293
pubmed: 30195083
Eur J Pharm Biopharm. 2015 Sep;95(Pt A):3-12
pubmed: 25770769
Trends Biochem Sci. 2017 Apr;42(4):245-254
pubmed: 27932073
Cell Rep. 2018 Mar 13;22(11):2924-2936
pubmed: 29539421
Eur J Pharm Biopharm. 2019 Apr;137:23-36
pubmed: 30779978
Nat Rev Immunol. 2018 Feb;18(2):134-147
pubmed: 28990587
Science. 2004 Mar 5;303(5663):1532-5
pubmed: 15001782
J Leukoc Biol. 2013 Feb;93(2):185-98
pubmed: 23066164
Nat Rev Mol Cell Biol. 2018 Apr;19(4):213-228
pubmed: 29339798
Semin Immunol. 2017 Dec;34:3-24
pubmed: 28941640
Nat Med. 2012 Sep;18(9):1386-93
pubmed: 22922410
Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):E10871-E10880
pubmed: 29208719
Chem Res Toxicol. 2013 Dec 16;26(12):1884-92
pubmed: 24191652
Nat Rev Immunol. 2012 Jun 15;12(7):492-502
pubmed: 22699831
Nat Immunol. 2014 Aug;15(8):727-37
pubmed: 24952505
Front Immunol. 2019 Feb 01;10:133
pubmed: 30774634
Toxicol Lett. 2013 Jul 31;221(1):57-63
pubmed: 23726862
Nanoscale. 2014 Dec 21;6(24):14686-90
pubmed: 25377797
J Leukoc Biol. 1996 Feb;59(2):229-40
pubmed: 8603995
Sci Rep. 2018 Jan 18;8(1):1115
pubmed: 29348435
Biochim Biophys Acta. 2015 Nov;1850(11):2276-82
pubmed: 26277637
J Leukoc Biol. 2019 Jul;106(1):95-103
pubmed: 30924969
Nanoscale. 2018 Jan 18;10(3):1180-1188
pubmed: 29271441
Nat Med. 2007 Apr;13(4):463-9
pubmed: 17384648
Adv Drug Deliv Rev. 2013 Dec;65(15):2087-97
pubmed: 23751779
Nat Immunol. 2014 Aug;15(8):738-48
pubmed: 24952504
Cell. 2017 Oct 5;171(2):273-285
pubmed: 28985560
Proc Natl Acad Sci U S A. 2016 Aug 30;113(35):9728-33
pubmed: 27528673
Nat Rev Drug Discov. 2018 Aug;17(8):588-606
pubmed: 30026524
Part Fibre Toxicol. 2014 May 11;11:22
pubmed: 24885671
Adv Healthc Mater. 2018 Feb;7(4):
pubmed: 29266859
Cell Death Dis. 2017 Jul 27;8(7):e2954
pubmed: 28749469
Nat Rev Immunol. 2009 Aug;9(8):581-93
pubmed: 19498381
Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14055-60
pubmed: 21844380
J Biol Chem. 1999 Nov 26;274(48):33835-8
pubmed: 10567338
Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):E5856-E5865
pubmed: 27647892
Nano Lett. 2010 Jan;10(1):59-63
pubmed: 19994869
Mol Cell. 2002 Aug;10(2):417-26
pubmed: 12191486
Adv Healthc Mater. 2013 Nov;2(11):1489-500
pubmed: 23554400
Science. 2008 Apr 18;320(5874):379-81
pubmed: 18420935
Semin Immunol. 2017 Dec;34:33-51
pubmed: 28869063
ACS Nano. 2011 Sep 27;5(9):6861-70
pubmed: 21800904
Small. 2012 Feb 6;8(3):404-12
pubmed: 22144073
Nature. 2009 Nov 26;462(7272):449-60
pubmed: 19940915
Toxicol In Vitro. 2016 Mar;31:12-22
pubmed: 26551149
Semin Immunopathol. 2018 Nov;40(6):567-575
pubmed: 30310974
Toxicol Appl Pharmacol. 2018 Sep 15;355:80-92
pubmed: 29959027
Front Immunol. 2012 Sep 17;3:287
pubmed: 23060876
Nanoscale. 2014 Apr 7;6(7):3488-95
pubmed: 24548972
FASEB J. 2008 Sep;22(9):3111-9
pubmed: 18509199
Acc Chem Res. 2013 Mar 19;46(3):733-42
pubmed: 22720979
Cell Death Differ. 2018 Mar;25(3):486-541
pubmed: 29362479
Toxicol In Vitro. 2014 Aug;28(5):926-31
pubmed: 24759804
Annu Rev Immunol. 2015;33:49-77
pubmed: 25493334
J Biol Chem. 2014 Feb 21;289(8):5320-9
pubmed: 24398679
Science. 2008 May 2;320(5876):674-7
pubmed: 18403674
Nat Rev Immunol. 2016 Jul;16(7):407-20
pubmed: 27291964
ACS Nano. 2014 Jun 24;8(6):5610-21
pubmed: 24871084
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15880-5
pubmed: 20798043
Sci Rep. 2017 Jul 26;7(1):6529
pubmed: 28747804
Swiss Med Wkly. 2012 Jun 26;142:w13609
pubmed: 22736064
Nat Mater. 2009 Jul;8(7):543-57
pubmed: 19525947
Nat Commun. 2018 Jun 19;9(1):2393
pubmed: 29921862
Blood. 1998 Dec 15;92(12):4808-18
pubmed: 9845548
Blood. 2010 Jun 3;115(22):4533-41
pubmed: 20304804
Sci Immunol. 2018 Aug 24;3(26):
pubmed: 30143554

Auteurs

Sandeep Keshavan (S)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Paolo Calligari (P)

Department of Chemical Sciences and Technologies, University of Rome Tor Vergata, Rome, Italy.

Lorenzo Stella (L)

Department of Chemical Sciences and Technologies, University of Rome Tor Vergata, Rome, Italy.

Laura Fusco (L)

Department of Chemical and Pharmaceutical Sciences, University of Trieste, Trieste, Italy.

Lucia Gemma Delogu (LG)

Department of Biomedical Sciences, University of Padua, Padua, Italy.
Fondazione Istituto di Ricerca Pediatrica Città della Speranza, Padua, Italy.

Bengt Fadeel (B)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. bengt.fadeel@ki.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH